Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$377,506,246
+$79,211,513 QoQ
Shares Held
7,869,632
+1.9% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. RPRX ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $377,506,246 | 7,869,632 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $298,294,733 | 7,719,843 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $268,742,330 | 7,617,413 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $294,599,438 | 8,176,504 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $249,023,438 | 7,999,468 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $186,543,175 | 7,312,551 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $205,549,085 | 7,265,786 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $180,589,565 | 6,848,296 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $198,864,399 | 6,548,054 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $178,866,192 | 6,367,611 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $165,596,175 | 6,101,554 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $188,923,859 | 6,145,864 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $215,896,299 | 5,992,126 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $230,274,898 | 5,826,794 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $211,818,272 | 5,271,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $212,347,739 | 5,051,088 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $195,175,925 | 5,009,649 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $211,369,261 | 5,304,122 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $150,633,290 | 4,168,049 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $81,352,279 | 1,984,686 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $84,206,229 | 1,930,450 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $62,687,975 | 1,252,507 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $45,639,345 | 1,084,843 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $40,309,802 | 830,274 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||